Heart health tests measure cholesterol, triglycerides, and key markers that show how well your heart and blood vessels are functioning. At Bids Chemist, early testing helps detect risks like high cholesterol and heart disease. With timely advice and care, you can take preventive action and maintain a healthy cardiovascular system.
This test measures angiotensin-converting enzyme (ACE) levels, which can be elevated in sarcoidosis and other granulomatous diseases. Blood is collected and analysed alongside clinical assessment. Monitoring ACE levels helps healthcare providers evaluate disease activity, guide therapy, and assess response to treatment. Early detection and ongoing monitoring support prevention of organ damage and effective management of systemic conditions. Patients benefit from accurate results, which enable proactive healthcare decisions and long-term disease control.
This test measures apolipoprotein A1, a protein component of high-density lipoprotein (HDL) cholesterol that helps remove cholesterol from the bloodstream. Low levels may increase the risk of cardiovascular disease. Blood is drawn, and results are interpreted alongside lipid profiles and other cardiovascular markers. Monitoring apolipoprotein A1 helps healthcare providers assess heart disease risk, guide lifestyle interventions, and tailor preventive strategies. Patients benefit from understanding their lipid transport and cardiovascular health, enabling informed choices about diet, exercise, and medications to reduce long-term risk.
This test measures apolipoprotein B, the main protein component of low-density lipoprotein (LDL) cholesterol. High levels indicate increased risk of cardiovascular disease, including atherosclerosis and heart attack. Blood is collected, and results are interpreted alongside LDL, HDL, and total cholesterol levels. Understanding apolipoprotein B levels helps healthcare providers assess cardiovascular risk, recommend lifestyle changes, and guide medications such as statins. Patients gain insight into their heart health and can take proactive steps to improve cholesterol management and reduce long-term cardiovascular complications.
“This test measures apolipoprotein E after 12 hours of fasting, which plays a critical role in lipid metabolism and cardiovascular health. Variations in apolipoprotein E can influence cholesterol levels and the risk of heart disease or Alzheimer’s disease. Blood is collected, and results are interpreted alongside other lipid markers. Understanding apolipoprotein E levels helps healthcare providers assess cardiovascular risk, guide lifestyle and dietary interventions, and support long-term preventive strategies. Patients benefit by gaining insight into their genetic and metabolic profile for heart and brain health. Important: Must fast 12 hours before appointment. “
This test measures brain natriuretic peptide (BNP or NT-pro BNP), a hormone released by the heart in response to stress or heart failure. Blood is drawn, and elevated levels may indicate heart strain, fluid overload, or cardiac dysfunction. Results help healthcare providers diagnose, monitor, and manage heart failure or related cardiovascular conditions. Understanding BNP levels allows patients to receive timely interventions, adjust medications, and implement lifestyle changes to support heart health. Early detection improves prognosis, reduces complications, and helps guide long-term cardiovascular care.
This panel measures cholesterol and lipid profiles, including HDL, LDL, and triglycerides. Blood is drawn and analysed to assess cardiovascular risk. Abnormal levels may indicate heart disease risk, metabolic syndrome, or lifestyle-related conditions. Results guide healthcare providers in recommending diet, exercise, or medications. Patients benefit from understanding their lipid status, enabling preventive measures and long-term cardiovascular health optimization.
This test measures total cholesterol in the blood, a critical marker for heart disease risk. Blood is drawn and analysed to determine lipid levels. Elevated cholesterol may increase the risk of atherosclerosis, heart attack, or stroke. Healthcare providers use results to guide dietary, lifestyle, or medication interventions. Patients benefit by gaining insight into heart health, reducing risk factors, and implementing strategies to maintain cardiovascular wellness.
This test measures the CK-MB fraction, an enzyme released by heart muscle when it is damaged. Blood is drawn and analysed to detect conditions such as myocardial infarction or cardiac injury. Early detection allows healthcare providers to provide immediate treatment, monitor recovery, and prevent further complications. Monitoring CK-MB levels helps track heart health, assess therapy effectiveness, and guide patient management. Patients benefit by receiving timely interventions and personalised care, improving cardiovascular outcomes and reducing long-term risks.
This high-sensitivity C-reactive protein (hs-CRP) test measures inflammation in the body. Blood is drawn and analysed to assess risk for cardiovascular disease, infection, or systemic inflammatory conditions. Elevated hs-CRP can prompt lifestyle interventions, further testing, or treatment plans. Patients benefit from early detection of inflammation, risk assessment for heart disease, and guidance on preventive strategies, supporting long-term health and wellness.
This profile evaluates multiple cardiovascular markers, including cholesterol, triglycerides, blood pressure indicators, and inflammatory proteins. Blood is drawn and analysed to assess risk factors for heart disease, stroke, and metabolic syndrome. Results help healthcare providers recommend lifestyle changes, medications, or preventive strategies. Patients benefit by understanding their heart health, identifying modifiable risk factors, and taking proactive steps to protect cardiovascular function. Early detection allows for timely intervention, better management of cholesterol and blood pressure, and long-term maintenance of heart and vascular health. Regular monitoring supports informed health decisions and improved outcomes.
Measures homocysteine levels, an amino acid linked to cardiovascular risk, vitamin B12 or folate deficiency, and other metabolic issues. Elevated levels may indicate increased risk of heart disease, stroke, or blood clots. Blood is drawn fasting, and results are interpreted alongside other cardiovascular and nutritional markers. Understanding homocysteine levels helps guide dietary adjustments, vitamin supplementation, and preventive strategies for long-term vascular health.
This test evaluates LDL7 subfractions, a type of “bad cholesterol” linked to cardiovascular risk. Blood is drawn and analysed to identify small dense LDL particles, which may increase atherosclerosis risk. Results allow healthcare providers to guide lifestyle, diet, or medication interventions to reduce cardiovascular disease risk. Patients benefit by understanding heart health, taking proactive steps to prevent heart disease, and optimising long-term cardiovascular wellness.
Lipoprotein(a) is a type of cholesterol particle associated with increased cardiovascular risk. Elevated Lp(a) can contribute to atherosclerosis and heart disease even when standard cholesterol levels are normal. The test is used to assess inherited risk factors and guide preventive strategies. Blood is drawn fasting, if recommended, and results are interpreted alongside other lipid markers. Understanding Lp(a) levels helps healthcare providers advise on lifestyle modifications, monitor heart disease risk, and determine if medications or specialised interventions are appropriate to reduce cardiovascular complications.
This test measures myoglobin in serum, a protein released from damaged muscle tissue. Blood is collected and analysed to assess muscle injury, cardiac events, or rhabdomyolysis. Early detection allows healthcare providers to implement therapy, monitor recovery, and prevent complications. Patients benefit by detecting injury early, supporting muscle and cardiovascular health, and maintaining long-term wellness.
This test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme linked to inflammation and cardiovascular risk. Blood is collected and analysed to evaluate vascular health and the risk for atherosclerosis or heart disease. Elevated levels indicate increased cardiovascular risk. Healthcare providers use results to guide lifestyle, diet, or medication interventions. Patients benefit by understanding vascular health, implementing preventive strategies, and supporting long-term cardiovascular wellness. Early detection allows proactive interventions to improve heart health outcomes.
This test measures very-low-density lipoprotein (VLDL) cholesterol in blood, which plays a role in lipid transport and cardiovascular risk. Blood is collected and analysed to assess heart disease risk, metabolic health, and cholesterol balance. Abnormal levels may contribute to atherosclerosis or cardiovascular complications. Healthcare providers use results to guide diet, lifestyle, or therapeutic interventions. Patients benefit by understanding lipid health, reducing cardiovascular risk, and supporting long-term wellness. Timely assessment allows proactive management and informed preventive care.
This test measures high-sensitivity troponin I in blood, a cardiac biomarker released during heart muscle injury. Blood is collected and analysed to detect early signs of myocardial infarction, heart stress, or other cardiac events. Elevated levels allow healthcare providers to diagnose heart attacks promptly, guide treatment, and prevent complications. Patients benefit by understanding cardiac risk, receiving timely interventions, and supporting long-term heart health. Accurate detection enables proactive management, early therapy, and overall wellness.
